1. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
- Author
-
Vijayakumar M, Lemos PA, Hoye A, Ong AT, Aoki J, Granillo GR, McFadden EP, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Cummins PA, and Serruys PW
- Subjects
- Aged, Aged, 80 and over, Angioplasty, Balloon, Coronary, Blood Vessel Prosthesis Implantation, Combined Modality Therapy, Female, Follow-Up Studies, Hospital Mortality, Humans, Male, Netherlands, Platelet Glycoprotein GPIIb-IIIa Complex antagonists & inhibitors, Platelet Glycoprotein GPIIb-IIIa Complex therapeutic use, Postoperative Complications etiology, Postoperative Complications mortality, Treatment Outcome, Coated Materials, Biocompatible therapeutic use, Coronary Artery Disease therapy, Immunosuppressive Agents therapeutic use, Sirolimus therapeutic use, Stents
- Abstract
Sirolimus-eluting stent (SES) implantation has been shown to reduce repeat revascularization in various randomized trials. The present study evaluated the outcomes after SES implantation in 46 octogenarian patients. SES implantation in octogenarians appears to be feasible and is associated with very small subsequent need for repeat target vessel revascularization at 1 year.
- Published
- 2004
- Full Text
- View/download PDF